• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活化的PLK1通过β-连环蛋白/STAT3信号通路促进多倍体巨癌细胞与子细胞的迁移和侵袭。

Activated PLK1 promotes the migration and invasion of polyploid giant cancer cells with daughter cells via β-catenin/STAT3 signaling pathway.

作者信息

Zhou Xinyue, Ning Yidi, Wang Xiaorui, Xu Jing, Liu Yandi, Zhang Mingqing, Zhang Shiwu

机构信息

Department of Pathology, Tianjin Union Medical Center, 190 Jieyuan Road, Hongqiao, Tianjin, 300071, People's Republic of China.

Nankai University Medical College, Tianjin, 300071, People's Republic of China.

出版信息

Hum Cell. 2025 Jul 28;38(5):136. doi: 10.1007/s13577-025-01252-5.

DOI:10.1007/s13577-025-01252-5
PMID:40719950
Abstract

The abundance of polyploid giant cancer cells (PGCCs) is correlated with malignant tumor progression. PGCCs divide asymmetrically to generate daughter cells with high invasive and migratory capacities. The objective of this study was to investigate the mechanism by which the overexpression of polo-like kinase 1 (PLK1) regulates the migration and invasion of PGCCs and their daughter cells (PDCs). In the present study, PGCC formation was induced by CoCl in Hct116 and LoVo cells. The mRNA expression and protein levels were detected using reverse transcription‒quantitative PCR and western blotting, respectively. The regulatory relationships among related proteins were determined via small molecule inhibitors, transient small interfering RNA (siRNA) transfection, and coimmunoprecipitation. Our findings indicated that CoCl induces PGCC formation and produces progeny cells with increased invasive and metastatic abilities. PLK1 was expressed in PDCs and showed altered subcellular localization. In addition, aurora kinase A (AURKA) activated PLK1 by phosphorylating it at serine 137 and threonine 210. Activated PLK1 first stabilizes β-catenin accumulation in the cytoplasm and subsequently promotes its entry into the nucleus. After entering the nucleus, β-catenin promotes the accumulation of the tyrosine 705 site of signal transducer and activator of transcription 3 (pSTAT3-Tyr705), which promotes the downstream expression of target proteins, such as cyclin D1, matrix metallopeptidase 2 (MMP2) and c-MYC, and EMT-associated proteins as transcription factors. Furthermore, STAT3 and PLK1 form a feedback loop, allowing STAT3 to regulate PLK1 expression. In conclusion, PLK1 phosphorylation at different sites regulates the transcriptional function of pSTAT3-Tyr705 by promoting β-catenin nuclear translocation. Furthermore, AURKA and STAT3 affected PLK1 expression.

摘要

多倍体巨癌细胞(PGCCs)的丰度与恶性肿瘤进展相关。PGCCs进行不对称分裂以产生具有高侵袭和迁移能力的子细胞。本研究的目的是探究polo样激酶1(PLK1)过表达调节PGCCs及其子细胞(PDCs)迁移和侵袭的机制。在本研究中,用氯化钴在Hct116和LoVo细胞中诱导PGCC形成。分别使用逆转录定量PCR和蛋白质印迹法检测mRNA表达和蛋白质水平。通过小分子抑制剂、瞬时小干扰RNA(siRNA)转染和免疫共沉淀确定相关蛋白质之间的调控关系。我们的研究结果表明,氯化钴诱导PGCC形成并产生具有增强侵袭和转移能力的子代细胞。PLK1在PDCs中表达并表现出亚细胞定位改变。此外,极光激酶A(AURKA)通过在丝氨酸137和苏氨酸210位点磷酸化激活PLK1。激活的PLK1首先稳定细胞质中β-连环蛋白的积累,随后促进其进入细胞核。进入细胞核后,β-连环蛋白促进信号转导和转录激活因子3(pSTAT3-Tyr705)酪氨酸705位点的积累,从而促进细胞周期蛋白D1、基质金属肽酶2(MMP2)和c-MYC等靶蛋白以及作为转录因子的EMT相关蛋白的下游表达。此外,STAT3和PLK1形成一个反馈环,使STAT3能够调节PLK1表达。总之,PLK1在不同位点的磷酸化通过促进β-连环蛋白核转位调节pSTAT3-Tyr705的转录功能。此外,AURKA和STAT3影响PLK1表达。

相似文献

1
Activated PLK1 promotes the migration and invasion of polyploid giant cancer cells with daughter cells via β-catenin/STAT3 signaling pathway.活化的PLK1通过β-连环蛋白/STAT3信号通路促进多倍体巨癌细胞与子细胞的迁移和侵袭。
Hum Cell. 2025 Jul 28;38(5):136. doi: 10.1007/s13577-025-01252-5.
2
Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.整合素 αVβ1 激活的 PYK2 通过 STAT3-VGF 轴促进非小细胞肺癌的进展。
Cell Commun Signal. 2024 Jun 6;22(1):313. doi: 10.1186/s12964-024-01639-1.
3
Phosphorylation of LZTS2 by PLK1 activates the Wnt pathway.LZTS2 被 PLK1 磷酸化激活 Wnt 通路。
Cell Signal. 2024 Aug;120:111226. doi: 10.1016/j.cellsig.2024.111226. Epub 2024 May 11.
4
Overexpression of oncogenic polo-like kinase 1 disrupts the invasiveness, cell cycle, and apoptosis in synovial sarcoma.致癌性polo样激酶1的过表达会破坏滑膜肉瘤的侵袭性、细胞周期和细胞凋亡。
J Transl Med. 2025 Jun 20;23(1):691. doi: 10.1186/s12967-025-06740-8.
5
DSG3 promotes bladder cancer growth and metastasis via AKT/GSK3β/β-catenin pathway.桥粒芯糖蛋白3(DSG3)通过AKT/糖原合成酶激酶3β/β-连环蛋白信号通路促进膀胱癌的生长和转移。
J Transl Med. 2025 Jul 2;23(1):729. doi: 10.1186/s12967-025-06754-2.
6
Knockdown of PLK1 suppresses malignant phenotypes and tumor growth in bladder cancer via activating Hippo pathway.敲低PLK1通过激活Hippo通路抑制膀胱癌的恶性表型和肿瘤生长。
Gen Physiol Biophys. 2025 Jul;44(4):259-274. doi: 10.4149/gpb_2025015.
7
Structural regulation of PLK1 activity: implications for cell cycle function and drug discovery.PLK1活性的结构调控:对细胞周期功能和药物发现的影响。
Cancer Gene Ther. 2025 May 16. doi: 10.1038/s41417-025-00907-7.
8
Molecular mechanisms of radiation resistance in colorectal cancer: in silico identification of AURKA, BIRC5 and PLK1 proteins as potential biomarkers.结直肠癌辐射抗性的分子机制:通过计算机模拟鉴定AURKA、BIRC5和PLK1蛋白作为潜在生物标志物
Int J Radiat Biol. 2025;101(7):685-697. doi: 10.1080/09553002.2025.2496079. Epub 2025 Apr 28.
9
Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma.Plk1 的过表达促进人食管鳞癌细胞的恶性进展。
J Cancer Res Clin Oncol. 2010 Jan;136(1):9-16. doi: 10.1007/s00432-009-0630-4.
10
Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.PLK1 和 Stat3 之间的相互激活促进食管癌细胞的存活和增殖。
Gastroenterology. 2012 Mar;142(3):521-530.e3. doi: 10.1053/j.gastro.2011.11.023. Epub 2011 Nov 19.

本文引用的文献

1
Huaier promotes sensitivity of colorectal cancer to oxaliplatin by inhibiting METTL3 to regulate the Wnt/β‑catenin signaling pathway.槐耳通过抑制 METTL3 调节 Wnt/β-catenin 信号通路促进结直肠癌对奥沙利铂的敏感性。
Oncol Rep. 2025 Jan;53(1). doi: 10.3892/or.2024.8840. Epub 2024 Nov 8.
2
Molecular mechanism of vimentin nuclear localization associated with the migration and invasion of daughter cells derived from polyploid giant cancer cells.与多倍体巨大癌细胞衍生的子细胞迁移和侵袭相关的波形蛋白核定位的分子机制。
J Transl Med. 2023 Oct 13;21(1):719. doi: 10.1186/s12967-023-04585-7.
3
PLK1-mediated phosphorylation of β-catenin enhances its stability and transcriptional activity for extracellular matrix remodeling in metastatic NSCLC.
PLK1 介导的 β-连环蛋白磷酸化增强了其稳定性,并使其转录活性增强,从而促进转移性非小细胞肺癌细胞外基质重塑。
Theranostics. 2023 Feb 5;13(3):1198-1216. doi: 10.7150/thno.79318. eCollection 2023.
4
Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN.2020年和2040年全球结直肠癌负担:来自全球癌症负担(GLOBOCAN)的发病率和死亡率估计
Gut. 2023 Feb;72(2):338-344. doi: 10.1136/gutjnl-2022-327736. Epub 2022 Sep 8.
5
Polyploid giant cancer cells and cancer progression.多倍体巨癌细胞与癌症进展。
Front Cell Dev Biol. 2022 Oct 5;10:1017588. doi: 10.3389/fcell.2022.1017588. eCollection 2022.
6
Scintigraphic Imaging of Neovascularization With Tc-3PRGD for Evaluating Early Response to Endostar Involved Therapies on Pancreatic Cancer Xenografts .用Tc-3PRGD进行新生血管闪烁成像以评估恩度参与的胰腺癌异种移植治疗早期反应
Front Oncol. 2021 Dec 15;11:792431. doi: 10.3389/fonc.2021.792431. eCollection 2021.
7
A Comprehensive Risk Assessment and Stratification Model of Papillary Thyroid Carcinoma Based on the Autophagy-Related LncRNAs.基于自噬相关长链非编码RNA的甲状腺乳头状癌综合风险评估与分层模型
Front Oncol. 2022 Feb 24;11:771556. doi: 10.3389/fonc.2021.771556. eCollection 2021.
8
Colorectal Cancer: From Pathophysiology to Novel Therapeutic Approaches.结直肠癌:从病理生理学到新型治疗方法
Biomedicines. 2021 Dec 8;9(12):1858. doi: 10.3390/biomedicines9121858.
9
The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis.Bcl9/Bcl9L 与 β-catenin 和 Pygopus 的相互作用促进乳腺癌的生长、侵袭和转移。
Oncogene. 2021 Oct;40(43):6195-6209. doi: 10.1038/s41388-021-02016-9. Epub 2021 Sep 20.
10
Polo-like kinase 1 (PLK1) signaling in cancer and beyond. Polo 样激酶 1(PLK1)信号在癌症及其他领域中的作用。
Biochem Pharmacol. 2021 Nov;193:114747. doi: 10.1016/j.bcp.2021.114747. Epub 2021 Aug 26.